erratum · 2025
Correction: Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab
0 citationsDOI: https://doi.org/10.1007/s00330-025-11530-3Open accessPDF reported by metadataFull text reported by metadata